Clariane stock rebounds above its €3.11 support level and gains 2.5%
The group of specialized retirement homes and home care services rebounds after a session that saw it briefly dip below a closely monitored technical threshold. It benefits from a stable Paris market, as its quarterly revenue is published today.
A support level breached then recovered during the session, ahead of third-quarter revenue
Clariane is trading at €3.23 and gaining 2.54% compared to the previous day (€3.15). The stock initially broke its €3.11 support level to touch a low of €3.10, before rising back above it and closing the gap. This recovery comes as the Clariane group publishes its third-quarter 2026 revenue today, following a decline of 17.18% over a month that had brought it to the lowest point of the past twelve months, as noted during its fall below €3.15 on October 22.
With a gain of 2.54%, the stock ranks among the notable gainers of the SBF 120 during the session.
A rebound that leaves the price far from its moving averages and balance sheet benchmarks
The price remains below its three moving averages: 1.52% below the MA20 (€3.28), 12.23% below the MA50 (€3.68) and 16.97% below the MA200 (€3.89).
The RSI at 38 indicates a still weak configuration, without any reversal signal. Among comparable stocks, Emeis gains 2.59% today, but has lost 8.26% over one month and 25.66% over three months.
On the fundamental side, at the publication of H1 2026 results on July 29, 2026, the group targeted an improvement in its EBITDA margin of 100 to 150 basis points by end of 2026, while citing inflationary pressure on its operational costs among its risks. The revenue published today will help assess this trajectory.
